Supplements / ADHD
Omega-3 and ADHD: look beyond “good for the brain.”
A nutrient’s role in the body does not establish that supplementing it treats ADHD symptoms.
Source-linked information, not individual medical advice. A qualified clinician should review this health content before public launch. Do not change treatment based on this page.
THE USEFUL DISTINCTION
A 2023 Cochrane review found high-certainty evidence of no effect on total parent-rated ADHD symptoms in children and adolescents, alongside some lower-certainty findings of improvement on other measures.[1]
What was reviewed?
The review included 37 trials involving more than 2,374 participants. It examined polyunsaturated fatty acid supplements, including omega-3 preparations, rather than one universal product.
Its strongest findings did not show improvement in total parent-rated ADHD symptoms. Some other improvement measures suggested benefit with lower certainty. Formulations, study methods, and follow-up varied.[1]
What not to conclude
This is not evidence that an omega-3 product reliably replaces ADHD treatment. It also does not answer every nutrition question or tell a clinician whether an individual has a dietary deficiency.
For a personal decision, ask which outcome is being targeted and whether the evidence matches the person, formulation, and intended use.
Who does this apply to?
Children and adolescents with ADHD in trials of polyunsaturated fatty acid supplements.
What remains uncertain?
The review’s searches ran through October 2021. The publication date is not the end date of its evidence search, and these findings are not an adult-specific assessment.
Questions for your clinician
These are conversation prompts, not a suggested treatment plan.
- Are we discussing nutrition, a deficiency, or an ADHD treatment claim?
- Does the evidence match my age and intended outcome?
- What interactions or other risks should be considered?
- What would we use to assess whether the approach is helpful?
Sources & context
Sources checked September 26, 2026. These links support this brief; they do not imply an endorsement of NeuroCoach.
- Gillies, Leach & Perez Algorta — Cochrane review, 2023 Peer-reviewed systematic review; searches through October 2021